Temporary increases in problem behavior and sleep disruption following decreases in medication: a descriptive analysis of conditional rates.

The team watched clients after doctors cut their psych meds. They tracked problem behavior and sleep minute-by-minute.

All clients had developmental disabilities. The study ran as a simple case series with no extra treatment.

Behavior spikes and sleepless nights showed up right after the dose dropped.

Both problems eased back to baseline within about seven days.

Laureano et al. (2023) saw a similar short bump in problem behavior. Their data came from the first five sessions of new treatments, not from med changes. The pattern is the same: brief storm, then calm.

Baker et al. (2025) mapped sleep trouble in rare genetic disorders. They found many triggers like anxiety and sensory issues. Koskentausta et al. (2007) add one more trigger to that list: sudden med reduction.

McCavert et al. (2026) and Greene et al. (2019) show high base rates of sleep problems in cerebral palsy and Down syndrome. The med-withdrawal spike in T et al. sits on top of an already shaky foundation.

You can now warn families that the first week after a dose drop may be rough. Schedule extra check-ins, keep the same bedtime routine, and ride out the wave instead of adding new drugs.